[{"status": "Terminated", "city": "Madison", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86405", "recalling_firm": "pH-D Feminine Health", "address_1": "305 Williams Ave", "address_2": "N/A", "postal_code": "37115-2626", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1627-2020", "product_description": "pH-D Feminine Health Boric Acid Vaginal Suppositories, 24 vaginal suppositories per box, 600 mg each, pH-D Feminine Health, LLC Madison, TN 37115, UPC Code: 3 49597 00044 5.", "product_quantity": "a. 37,000 boxes; b. 45,000 boxes; c. 6,100 boxes", "reason_for_recall": "Marketed without an Approved NDA/ANDA.", "recall_initiation_date": "20200902", "center_classification_date": "20200930", "termination_date": "20220225", "report_date": "20201007", "code_info": "Lot #: a) 2PA20021, 2PA20061; b) D-160, D-155, D-162; c) 7PA20071."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0769-2020", "product_description": "SUFENTANIL 55.5 MCG/ML IN 18ML  INJ in 18 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@19 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Ongoing", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85781", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "N/A", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1343-2020", "product_description": "amneal Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, Rx Only, 100 count bottles, Distributed by: Amneal Pharmaceuticals LLC Bridgewater, NJ 08807  NDC 53746-0178-01", "product_quantity": "192", "reason_for_recall": "CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level", "recall_initiation_date": "20200529", "center_classification_date": "20200625", "report_date": "20200701", "code_info": "HA07419A 1/31/2021  HB00119A 1/31/2021  HB00219A 1/31/2021  HB00319A 1/31/2021;  HB00419A 2/28/2021  HB00519A 2/28/2021  HB00619A 2/28/2021  HB00719A 2/28/2021  HB00819A 2/28/2021  HB00919A 2/28/2021  HB01019A 2/28/2021  HB05119A 2/28/2021  HB05219A 2/28/2021  HB05319A 2/28/2021  HB05419A 2/28/2021  HB05519A 2/28/2021  HB09519A 2/28/2021  HB09619A 2/28/2021  HB09719A 2/28/2021  HB09819A 2/28/2021  HB09919A 2/28/2021;   HC08219A 3/31/2021  HC08319A 3/31/2021  HC08419A 3/31/2021  HC08519A 3/31/2021  HC09019A 3/31/2021  HC09119A 3/31/2021  HC09219A 3/31/2021  HC09319A 3/31/2021  HC09419A 3/31/2021;   HD03419B 4/30/2021  HD03519B 4/30/2021  HD03619B 4/30/2021  HD03719B 4/30/2021  HD03819B 4/30/2021  HD03919B 4/30/2021  HD04019B 4/30/2021  HD04119B 4/30/2021  HD04219A 4/30/2021  HD05819A 4/30/2021  HD05919A 4/30/2021  HD06019A 4/30/2021  HD06119A 4/30/2021  HD06219A 4/30/2021  HD06319A 4/30/2021  HD06419A 4/30/2021  HD09019A 4/30/2021  HD09119A 4/30/2021  HD09219A 4/30/2021  HE01219B 4/30/2021  HE01319B 4/30/2021  HE01419B 4/30/2021  HE01519B 4/30/2021;   HE01619A 5/31/2021  HE01719A 5/31/2021  HE01819A 5/31/2021  HE04419A 5/31/2021  HE04519A 5/31/2021  HE04619A 5/31/2021  HE04719A 5/31/2021  HE04819A 5/31/2021  HE04919A 5/31/2021  HE05019A 5/31/2021  HE05119A 5/31/2021  HE05219A 5/31/2021  HE05319A 5/31/2021  HE07219A 5/31/2021  HE07319A 5/31/2021  HE07419A 5/31/2021  HE07519A 5/31/2021  HE07619A 5/31/2021  HF02219A 5/31/2021  HF02319A 5/31/2021;  HF02419A 6/30/2021  HF02519A 6/30/2021  HF02619A 6/30/2021  HF02719A 6/30/2021  HF02819A 6/30/2021  HF02919A 6/30/2021  HF03019A 6/30/2021  HF03119A 6/30/2021  HF03219A 6/30/2021  HF03319A 6/30/2021  HF05419A 6/30/2021;  HF03918A 6/30/2020  HF04018A 6/30/2020  HF04118A 6/30/2020  HF04218A 6/30/2020  HF04318A 6/30/2020  HF04418A 6/30/2020  HF06518A 6/30/2020  HF06818B 6/30/2020  HF06918B 6/30/2020  HF07018B 6/30/2020  HF07118B 6/30/2020  HF07218A 6/30/2020  HF07318A 6/30/2020  HF07418A 6/30/2020  HF08318A 6/30/2020  HF08418A 6/30/2020  HF08518A 6/30/2020;  HF11219A 6/30/2021  HF11319A 6/30/2021  HF11419A 6/30/2021  HF11519A 6/30/2021  HF11619A 6/30/2021  HF11719A 6/30/2021  HF11819A 6/30/2021  HF11919A 6/30/2021  HF12019A 6/30/2021  HG00719A 6/30/2021  HG00819A 6/30/2021  HG00919A 6/30/2021  HG01019A 6/30/2021  HG01119A 6/30/2021  HG01219A 6/30/2021  HG01319A 6/30/2021  HG01419A 6/30/2021;  HG01519A 7/31/2021  HG01619A 7/31/2021  HG02919A 7/31/2021  HG03019A 7/31/2021  HG03119A 7/31/2021  HG03219A 7/31/2021  HG03319A 7/31/2021  HG03419A 7/31/2021  HG03519A 7/31/2021  HG03619A 7/31/2021  HG03719A 7/31/2021  HG03819A 7/31/2021;  HH08218A 8/31/2020  HH08318A 8/31/2020  HH08418A 8/31/2020  HH08518A 8/31/2020  HH08618A 8/31/2020  HH08718A 8/31/2020  HH08818A 8/31/2020  HH08918A 8/31/2020  HH09018A 8/31/2020  HH09118A 8/31/2020  HH09218A 8/31/2020  HH09318A 8/31/2020  HH09418A 8/31/2020  HH09518A 8/31/2020  HH09618A 8/31/2020  HH11218A 8/31/2020  HH11318A 8/31/2020  HH11418A 8/31/2020  HH11518A 8/31/2020;  HH11618A 9/30/2020  HH11718A 9/30/2020  HJ04818A 9/30/2020  HJ04918A 9/30/2020  HJ08518A 9/30/2020;  HJ08618A 10/31/2020  HJ08718A 10/31/2020  HJ08818A 10/31/2020  HJ08918A 10/31/2020  HJ09018A 10/31/2020  HJ09118A 10/31/2020  HK03718A 10/31/2020  HK03818A 10/31/2020  HK03918A 10/31/2020  HK04018A 10/31/2020  HK04118A 10/31/2020  HK04218A 10/31/2020  HK04318A 10/31/2020  HK04418A 10/31/2020  HK04518A 10/31/2020  HK04618A 10/31/2020  HK09318A 10/31/2020  HK09418A 10/31/2020  HK09518A 10/31/2020  HK09618A 10/31/2020  HK09718A 10/31/2020;  HM00218A 12/31/2020  HM00318A 12/31/2020  HM00418A 12/31/2020  HM00518A 12/31/2020  HM00618B 12/31/2020  HM00718B 12/31/2020  HM00818B 12/31/2020  HM00918B 12/31/2020  HM01018B 12/31/2020;  HM02918A 1/31/2021  HM03018A 1/31/2021  HM03218A 1/31/2021  HM03318A 1/31/2021  HM03418A 1/31/2021  HM03518A 1/31/2021  HM03618A 1/31/2021  HM03718A 1/31/2021  HM03818A 1/31/2021"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0973-2020", "product_description": "MIC-B12 Injection, MIC-B12 25MG/50MG/50MG/1MG/ML INJECTABLE, For IM Use, Refrigerate. Protect From Light, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0230-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 07102019+52618, Exp 2/8/2020; 09052019+52880, Exp 4/5/2020; 10012019+52983, Exp 5/1/2020; 11052019+53188, Exp 6/5/2020; 12112019+53367, Exp 7/11/2020"}, {"country": "United States", "city": "Jackson", "address_1": "N168w22223 Main St", "reason_for_recall": "cGMP violations", "address_2": "", "product_quantity": "44,373 cartons", "code_info": "Lot #:  a) 81827, Exp 8/2020; 111872, Exp 11/2020; 41970, Exp 4/2021; 519104, Exp 5/2021; b) 81827, Exp 8/2020; 111872, Exp 11/2020; 41970, Exp 4/2021.", "center_classification_date": "20200116", "distribution_pattern": "OR", "state": "WI", "product_description": "Yeast Arrest, Homeopathic Formula, Vaginal Support suppositories, packaged in a) 14-count carton (NDC 68093-0730-1 and 68093-0730-3), b) 28-count carton (NDC 68093-0730-2 and 68093-0730-4), Manufactured for: Vitanica, 12401 SW Leveton Drive, Tualatin, OR 97062.", "report_date": "20200122", "classification": "Class II", "openfda": {}, "recalling_firm": "Wisconsin Pharmacal Company, LLC", "recall_number": "D-0781-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84291", "termination_date": "20201106", "more_code_info": "", "recall_initiation_date": "20191114", "postal_code": "53037", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0688-2020", "product_description": "BUP 1MG//ML/HYDROM 7MG  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12112019@10 Exp. 12/20/2019", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA050608"], "brand_name": ["UNASYN"], "generic_name": ["AMPICILLIN SODIUM AND SULBACTAM SODIUM"], "manufacturer_name": ["Roerig"], "product_ndc": ["0049-0013", "0049-0014"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["AMPICILLIN SODIUM", "SULBACTAM SODIUM"], "rxcui": ["1659592", "1659595", "1659598", "1659600"], "spl_id": ["6b0299f2-a683-4c8f-bf62-b79d5f652b41"], "spl_set_id": ["155c7ec0-5862-404f-b1d0-f278f8a8bbda"], "package_ndc": ["0049-0013-81", "0049-0013-83", "0049-0014-81", "0049-0014-83"], "is_original_packager": [true], "unii": ["JFN36L5S8K", "DKQ4T82YE6"]}, "product_type": "Drugs", "event_id": "85754", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-1306-2020", "product_description": "Unasyn (ampicillin sodium/sulbacatam) for injection, 1.5 g* per vial, Rx Only, 10 vials/carton, Made in Italy Distributed by Roerig Division of Pfizer Inc. New York, NY 10017 vial NDC 0049-0013-81, carton NDC 0049-0013-83", "product_quantity": "94320 units", "reason_for_recall": "Presence of Particulate Matter: particulate matter identified after reconstitution.", "recall_initiation_date": "20200529", "center_classification_date": "20200612", "termination_date": "20220113", "report_date": "20200617", "code_info": "Lot # 3301612, EXP 02/2022"}, {"status": "Ongoing", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86799", "recalling_firm": "Advanced Nutriceuticals, LLC", "address_1": "836 E 86th St", "address_2": "N/A", "postal_code": "46240-1806", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, CO, FL, IN, KY, OH, TX", "recall_number": "D-0134-2021", "product_description": "IPAMORELIN, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN", "product_quantity": "3 vials", "reason_for_recall": "Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.", "recall_initiation_date": "20201130", "center_classification_date": "20201211", "report_date": "20201223", "code_info": "Lot # 1029202005,Exp 11/29/2020;  Lot #1102202014, Exp 12/08/2020;  Lot #1112202002, Exp 12/12/2020"}, {"country": "United States", "city": "Indiana", "address_1": "625 Kolter Dr Ste 4", "reason_for_recall": "Presence of Particulate Matter: Medication relabeled at facility was recalled by the manufacturer due to small black particles noticed during routine visual inspection. of retain samples.", "address_2": "", "product_quantity": "75 1 ml vials", "code_info": "Lot # B0444562-060118, exp. 04/2020, B0537002-112118, exp 07/2020", "center_classification_date": "20200303", "distribution_pattern": "Product distributed in OK and LA.", "state": "PA", "product_description": "Ketorolac Trom, 30 mg/1mL Inj. for I.V./I.M. Use, Rx Only, QTY: 1 ml, Repackaged by: RemedyRepack Inc., Indiana, PA 15701 NDC 70518-1239-00", "report_date": "20200219", "classification": "Class I", "openfda": {}, "recalling_firm": "RemedyRepack Inc.", "recall_number": "D-0867-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84900", "termination_date": "20200818", "more_code_info": "", "recall_initiation_date": "20191227", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86343", "recalling_firm": "RLC Labs Inc.", "address_1": "1850 E Riverview Dr", "address_2": "N/A", "postal_code": "85034-6703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-1618-2020", "product_description": "Nature Throid, 2 Grain (130 mg) Thyroid USP [Liothyronine (T3) 18 mcg, Levothyroxine (T4) 76 mcg], packaged in a) 30-count bottles (NDC 64727-3308-4) and b)100-count bottles (NDC 64727-3308-1), Rx only,  Manufactured by: RLC Labs Phoenix, AZ 85024", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug: FDA analysis found product to be subpotent", "recall_initiation_date": "20200825", "center_classification_date": "20200924", "termination_date": "20231108", "report_date": "20200923", "code_info": "Lot #: 109264, Exp. Date 10/2022"}, {"status": "Completed", "city": "Jenison", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85854", "recalling_firm": "MICHIGAN HERBAL REMEDIES", "address_1": "904 Chicago Dr", "address_2": "", "postal_code": "49428-9351", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide via internet sales,retailers and distributors in the USA", "recall_number": "D-1470-2020", "product_description": "Tasty Drops, Hemp Oil Extract, Berry, 500MG CBD, 1 FL. OZ (30ML) bottles, Dist by: Tasty Hemp Oil, Jenison, MI, UPC 6 96305 29083 5", "product_quantity": "201 bottles", "reason_for_recall": "Chemical contamination: product contains elevated levels of undeclared lead.", "recall_initiation_date": "20200618", "center_classification_date": "20200804", "report_date": "20200812", "code_info": "FG003137, FG003174, FG003197, FG0057", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0779-2020", "product_description": "TRIMIX SUPER (A) 30MG/2MG/30MCG/ML INJ in 1 mL vial  Assurance Infusion (713) 533-8800", "product_quantity": "45 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 10152019@23 Exp. 03/04/2020; 10302019@27 Exp. 04/27/2020; 08052019@19 Exp. 02/01/2020; 10032019@14 Exp. 03/31/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Mesquite", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M017"], "brand_name": ["REGENECARE HA"], "generic_name": ["LIDOCAINE HCL"], "manufacturer_name": ["MPM Medical LLC"], "product_ndc": ["66977-107"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["LIDOCAINE HYDROCHLORIDE"], "rxcui": ["1011852", "2604879"], "spl_id": ["18ad4e40-89c3-b48f-e063-6294a90a2280"], "spl_set_id": ["c3eec066-38e8-4617-b34d-2f72ffb7a324"], "package_ndc": ["66977-107-03"], "is_original_packager": [true], "unii": ["V13007Z41A"]}, "product_type": "Drugs", "event_id": "86767", "recalling_firm": "MPM Medical LLC", "address_1": "1801 Big Town Blvd Ste 300", "address_2": "N/A", "postal_code": "75149-1030", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0118-2021", "product_description": "REGENECARE HA (Lidocaine HCL 2%) Topical Anesthetic Hydrogel, Net Wt. 3 oz. (85 g),  Manufactured For: MPM Medical Mesquite, TX 75149. NDC 66977-107-03", "product_quantity": "7,637 tubes", "reason_for_recall": "Microbial Contamination of Non-Sterile Drug Product. The product was found to be contaminated with the bacteria Burkholderia cepecia.", "recall_initiation_date": "20201117", "center_classification_date": "20201207", "termination_date": "20220908", "report_date": "20201209", "code_info": "Lot: 41262 Exp. 01/21", "more_code_info": ""}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200816"], "brand_name": ["LANSOPRAZOLE"], "generic_name": ["LANSOPRAZOLE"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-771", "68382-772"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LANSOPRAZOLE"], "rxcui": ["351260", "351261"], "spl_id": ["3de4f129-dc87-48e1-b934-b2a038df8cf7"], "spl_set_id": ["9b3869ad-f2f7-4954-b75c-5c23b8951635"], "package_ndc": ["68382-771-30", "68382-771-77", "68382-772-30", "68382-772-77"], "is_original_packager": [true], "nui": ["N0000175525", "N0000000147", "N0000009724"], "pharm_class_epc": ["Proton Pump Inhibitor [EPC]"], "pharm_class_moa": ["Proton Pump Inhibitors [MoA]"], "pharm_class_pe": ["Inhibition Gastric Acid Secretion [PE]"], "unii": ["0K5C5T2QPG"]}, "product_type": "Drugs", "event_id": "86663", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0074-2021", "product_description": "Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-771-77", "product_quantity": "6,840 units", "reason_for_recall": "Failed Dissolution Specification", "recall_initiation_date": "20201027", "center_classification_date": "20201110", "termination_date": "20221220", "report_date": "20201111", "code_info": "Lot # M005681, EXP 3/2022"}, {"status": "Completed", "city": "Jenison", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85854", "recalling_firm": "MICHIGAN HERBAL REMEDIES", "address_1": "904 Chicago Dr", "address_2": "", "postal_code": "49428-9351", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide via internet sales,retailers and distributors in the USA", "recall_number": "D-1479-2020", "product_description": "BC Hemp Co., Full Spectrum Hemp Extract, CBD Oil, Natural, 1000MG CBD, 1 FL. OZ (30 ML) bottles, Distributed by: B.C. Hemp Co., LLC, P.O. Box 156, Eau Claire, MI 49111", "product_quantity": "25 bottles", "reason_for_recall": "Chemical contamination: product contains elevated levels of undeclared lead.", "recall_initiation_date": "20200618", "center_classification_date": "20200804", "report_date": "20200812", "code_info": "FG003318", "more_code_info": ""}, {"status": "Terminated", "city": "Badepalle", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86191", "recalling_firm": "Hetero Labs Limited (Unit V)", "address_1": "458 Surv No 439 - 441", "address_2": "Polepally Village", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to major wholesalers/distributors throughout the United States.", "recall_number": "D-1545-2020", "product_description": "Losartan Potassium Tablets USP, 50 mg, 90 count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ by Hetero Labs, Limited, Mahabubragar, India", "product_quantity": "43,512 bottles", "reason_for_recall": "Failed Tablet/Capsule Specification; complaint of bulging tablet", "recall_initiation_date": "20200806", "center_classification_date": "20200826", "termination_date": "20220124", "report_date": "20200902", "code_info": "Batch # LOA19357A, exp. date 09/2021"}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200816"], "brand_name": ["LANSOPRAZOLE"], "generic_name": ["LANSOPRAZOLE"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-771", "68382-772"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LANSOPRAZOLE"], "rxcui": ["351260", "351261"], "spl_id": ["3de4f129-dc87-48e1-b934-b2a038df8cf7"], "spl_set_id": ["9b3869ad-f2f7-4954-b75c-5c23b8951635"], "package_ndc": ["68382-771-30", "68382-771-77", "68382-772-30", "68382-772-77"], "is_original_packager": [true], "nui": ["N0000175525", "N0000000147", "N0000009724"], "pharm_class_epc": ["Proton Pump Inhibitor [EPC]"], "pharm_class_moa": ["Proton Pump Inhibitors [MoA]"], "pharm_class_pe": ["Inhibition Gastric Acid Secretion [PE]"], "unii": ["0K5C5T2QPG"]}, "product_type": "Drugs", "event_id": "86663", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0075-2021", "product_description": "Lansoprazole Delayed-Release Orally Disintegrating Tablets 30 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-772-77", "product_quantity": "7,908 units", "reason_for_recall": "Failed Dissolution Specification", "recall_initiation_date": "20201027", "center_classification_date": "20201110", "termination_date": "20221220", "report_date": "20201111", "code_info": "Lot # M005682, EXP 3/2022"}, {"status": "Terminated", "city": "Lake Zurich", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA208129"], "brand_name": ["DEXMEDETOMIDINE HYDROCHLORIDE"], "generic_name": ["DEXMEDETOMIDINE HYDROCHLORIDE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-671"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["DEXMEDETOMIDINE HYDROCHLORIDE"], "rxcui": ["1718900", "1718906", "1718909"], "spl_id": ["27411591-44a1-44c4-89c3-dd8c2687f0e2"], "spl_set_id": ["4d5d2294-89a0-4b6f-aa00-d39a0393b6a8"], "package_ndc": ["63323-671-02", "63323-671-20", "63323-671-05", "63323-671-50", "63323-671-01", "63323-671-00"], "is_original_packager": [true], "upc": ["0363323671020", "0363323671051"], "unii": ["1018WH7F9I"]}, "product_type": "Drugs", "event_id": "86766", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3 Corporate Dr", "address_2": "N/A", "postal_code": "60047-8930", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0120-2021", "product_description": "Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg / 50 mL (4 mcg / mL), 50 mL Single Dose Bottle, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-671-05", "product_quantity": "13,525 bottles", "reason_for_recall": "Cross Contamination with other products: trace amounts of lidocaine", "recall_initiation_date": "20201117", "center_classification_date": "20201208", "termination_date": "20220912", "report_date": "20201216", "code_info": "Lot #: 6123925"}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1204-2020", "product_description": "Testosterone in Atrevis 50 mg/mL Gel 30 gm tube, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 tube", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 44488 Discard by: 8/22/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1175-2020", "product_description": "Estriol Vaginal Cream (0.1%) 1 mg Cream 30 GM tubes, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "8 tubes", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45036 Discard by: 7/31/2020; 45075 Discard by:8/7/2020", "more_code_info": ""}, {"country": "United States", "city": "Baltimore", "address_1": "Harborplace Tower", "reason_for_recall": "Failed Tablet/Capsule Specifications: Complaints related to crumbling of tablets when popped out of the blister pack.", "address_2": "111 S Calvert St Fl 21st", "product_quantity": "41,863 cartons/3 wallets per carton", "code_info": "Lot: H801227, Exp. Date January 2020", "center_classification_date": "20200103", "distribution_pattern": "Nationwide within the United States", "state": "MD", "product_description": "Blisovi Fe  1.5/30 (norethindrone acetate and ethinyl estradiol tablets USP and ferrous fumarate tablets 75mg), Rx Only, Distributed by: Lupin Pharmaceuticals Inc Baltimore, MD 21202, Manufactured for: Lupin Limited Pithampur 454775 INDIA 240875, NDC 68180-866-11", "report_date": "20200115", "classification": "Class II", "openfda": {}, "recalling_firm": "Lupin Pharmaceuticals Inc.", "recall_number": "D-0638-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84571", "termination_date": "20201022", "recall_initiation_date": "20191226", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M005"], "brand_name": ["HEB"], "generic_name": ["CLOTRIMAZOLE"], "manufacturer_name": ["H E B"], "product_ndc": ["37808-305"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CLOTRIMAZOLE"], "rxcui": ["309367"], "spl_id": ["39adf5d6-2001-9513-e063-6294a90a14c5"], "spl_set_id": ["8f07dc5a-cfa8-4a57-ac90-552a7c947cc5"], "package_ndc": ["37808-305-01"], "is_original_packager": [true], "nui": ["N0000175487", "M0002083"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_cs": ["Azoles [CS]"], "unii": ["G07GZ97H65"]}, "product_type": "Drugs", "event_id": "86833", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "N/A", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA and Canada", "recall_number": "D-0152-2021", "product_description": "H-E-B - Athlete's Foot Cream Clotrimazole Cream USP, 1% Anitfungal NET WT. 0.5 oz. (14.2 g),  Made with Pride & Care for H-E-B San Antonio, TX 78204 Made in Canada NDC 37808-305-01", "product_quantity": "N/A", "reason_for_recall": "Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.", "recall_initiation_date": "20201117", "center_classification_date": "20201216", "termination_date": "20240221", "report_date": "20201223", "code_info": "Lot#: A873630558 Dec-2020; D867331276, Exp Mar-2021"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1145-2020", "product_description": "Nasal Ez, 500mg Capsules, 90-count bottles, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0974-2020", "product_description": "MIC-PLEX Injection, Vitamin Complex, MIC-COMBO* 25MG/50MG/50MG/1MG/20MG/5MG/ML INJECTABLE, For IM Use, Protect From Light, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0233-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 11212019+53263, Exp 2/16/2020; 11252019+53276, Exp 2/20/2020"}, {"status": "Terminated", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84671", "recalling_firm": "Preferred Pharmaceuticals, Inc", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distribution to physicians in the following states: AL, AZ, CA, FL, GA, IN, and  SC", "recall_number": "D-0797-2020", "product_description": "Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 300 mg, Rx Only, a) 14 count bottles (NDC: 68788-6382-1), b) 30 count bottles (NDC: 68788-6382-3), c) 90 count bottles (NDC: 68788-6382-9), d) 100 count bottles (NDC: 68788-6382-0)", "product_quantity": "39,172 tablets", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20200107", "center_classification_date": "20200120", "termination_date": "20231214", "report_date": "20200129", "code_info": "Lot #: All lots within expiry", "more_code_info": ""}, {"status": "Completed", "city": "Jenison", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85854", "recalling_firm": "MICHIGAN HERBAL REMEDIES", "address_1": "904 Chicago Dr", "address_2": "", "postal_code": "49428-9351", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide via internet sales,retailers and distributors in the USA", "recall_number": "D-1474-2020", "product_description": "Tasty Drops, Hemp Oil Extract, Spearmint, 1000MG CBD, 1 FL. OZ (30ML) bottles, Dist by: Tasty Hemp Oil, Jenison, MI, UPC 8 02991 76539 1", "product_quantity": "391 bottles", "reason_for_recall": "Chemical contamination: product contains elevated levels of undeclared lead.", "recall_initiation_date": "20200618", "center_classification_date": "20200804", "report_date": "20200812", "code_info": "FG003095", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0705-2020", "product_description": "BUP 3MG/HYDROM 15MG/ML INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@1 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Lincoln", "state": "NE", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84931", "recalling_firm": "GSK Consumer Health, Inc", "address_1": "10401 Hwy 6", "address_2": "", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0996-2020", "product_description": "Theraflu Cough Relief, Dextromethorphan HBr and Guaifensin, 6 packets per carton. Distributed by: GSK Consumer Healthcare, Warren, NJ 07059. NDC carton: 0067-6089-01, NDC packet: 0067-6089-03", "product_quantity": "431,614 cartons", "reason_for_recall": "Labeling: Label Lacks Warning: Product recalled due to absence of a warning statement on the product label,  Ask a doctor before use if you have a sodium-restricted diet.", "recall_initiation_date": "20191223", "center_classification_date": "20200307", "termination_date": "20230309", "report_date": "20200219", "code_info": "Lot: K79A, K79B, K79C, exp 3/31/2021; XB2W, Y23L, Y23V, exp 5/31/2021; 19N1793000, 19N1895942, 19N1952247, 19N1884668, 19N1936498, 19N1936583, exp 3/31/2021; 19N1920630, 19N1958240, exp 4/30/2021;  19N1957675, M926001MA, M926002MA, M926003MA, M926004MA,  M926005MA, M926006MA, M926007MA, M926008MA, M926009MA, M926201MA, M926202MA, exp 5/31/2021; M926201MB, M926202MB, M926203MB, M926204MB, M926205MB, M926206MB, M926207MB, M926208MB, M926209MB, exp 2/28/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0778-2020", "product_description": "TRIMIX FORTE PLUS 30MG/4MG/40MCG/ML INJ in 1 mL vial Assurance Infusion (713) 533-8800", "product_quantity": "20 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 07032019@12 Exp. 12/30/2019; 08212019@32 Exp. 02/17/2020; 10032019@12 Exp. 03/31/2020", "more_code_info": ""}, {"country": "United States", "city": "Allegan", "address_1": "515 Eastern Ave", "reason_for_recall": "CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.", "address_2": "", "product_quantity": "", "code_info": "Lots:8EE1514,   8EE1515,   8FE1353,   8GE1732,   8GE1864,   8HE1652,   8HE1653,   8JE2235,   8KE2724,   8KE2725,   8LE2367,   8ME2643,   8ME2644,   9AE2766,   9AE2767,   9CE3273,   9CE3274,   9DE2629,   9DE2630,   9EE2516,   9EE2517,   9FE2915,   9FE2916,   9GE2694,   9GE3144", "center_classification_date": "20200313", "distribution_pattern": "Nationwide USA", "state": "MI", "product_description": "Maximum Strength Acid Reducer, Cool Mint Ranitidine tablets, USP 150 mg, 90 tablets per bottle. [Brand, NDC] NDC Equate: 49035-800-75; NDC Up & Up: 11673-950-75", "report_date": "20200325", "classification": "Class II", "openfda": {}, "recalling_firm": "Perrigo Company PLC", "recall_number": "D-1025-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84127", "termination_date": "20201106", "more_code_info": "", "recall_initiation_date": "20191023", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84527", "recalling_firm": "MPRX, Inc. dba Medical Park Pharmacy", "address_1": "8230 Elmbrook Dr Ste 600b", "address_2": "N/A", "postal_code": "75247-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0803-2020", "product_description": "DHEA/Pregnenol One 10.25 MG Cap", "product_quantity": "1 bottle", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.", "recall_initiation_date": "20191218", "center_classification_date": "20200129", "termination_date": "20221213", "report_date": "20200205", "code_info": "Lot: L61406:42 Use by: 05/06/2020"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84527", "recalling_firm": "MPRX, Inc. dba Medical Park Pharmacy", "address_1": "8230 Elmbrook Dr Ste 600b", "address_2": "N/A", "postal_code": "75247-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0818-2020", "product_description": "Tadalafil 20 mg Troche", "product_quantity": "9 bottles", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.", "recall_initiation_date": "20191218", "center_classification_date": "20200129", "termination_date": "20221213", "report_date": "20200205", "code_info": "Lots: 61137:42 Use by: 03/08/2020; 61324:99 Use by: 04/04/2020; 60856:42 Use by: 02/02/2020"}, {"status": "Ongoing", "city": "North Blenheim", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86593", "recalling_firm": "Denton Pharma, Inc.", "address_1": "119 Creamery Rd", "address_2": "N/A", "postal_code": "12131-1613", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Indiana - Nationwide.", "recall_number": "D-0056-2021", "product_description": "Metformin Hydrochloride Extended-Release Tablets USP 750 mg, 30 Tablets bottle, Rx Only, Time-Cap Labs, Inc., Repackaged By: Northwind Pharmaceuticals North Blenheim NY 12131  NDC 70934-334-30", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)", "recall_initiation_date": "20201008", "center_classification_date": "20201102", "report_date": "20201111", "code_info": "N107411901, N107411903, N107411904, N107411905, N107411906, exp 11/30/2020;   N107411907, N107412001, exp 4/30/2021;   N107412002, N107412004, exp 11/30/2021;   N107412003, exp 7/31/2021"}, {"status": "Ongoing", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86799", "recalling_firm": "Advanced Nutriceuticals, LLC", "address_1": "836 E 86th St", "address_2": "N/A", "postal_code": "46240-1806", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, CO, FL, IN, KY, OH, TX", "recall_number": "D-0130-2021", "product_description": "PT-141, 10 MG/ML, 2 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.", "recall_initiation_date": "20201130", "center_classification_date": "20201211", "report_date": "20201223", "code_info": "Lot #1112202006, Exp 12/12/2020"}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078295"], "brand_name": ["SUMATRIPTAN SUCCINATE"], "generic_name": ["SUMATRIPTAN SUCCINATE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["62756-520", "62756-521", "62756-522"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SUMATRIPTAN SUCCINATE"], "spl_id": ["9035f04f-b353-4883-9ac2-e030f18bfc1c"], "spl_set_id": ["9485cc30-15e8-4b53-876d-db317145474b"], "package_ndc": ["62756-520-83", "62756-520-88", "62756-520-08", "62756-520-18", "62756-520-69", "62756-520-93", "62756-520-01", "62756-521-83", "62756-521-88", "62756-521-08", "62756-521-18", "62756-521-69", "62756-521-93", "62756-521-01", "62756-522-83", "62756-522-88", "62756-522-08", "62756-522-18", "62756-522-69", "62756-522-93", "62756-522-01"], "is_original_packager": [true], "upc": ["0362756521889", "0362756522886"], "unii": ["J8BDZ68989"]}, "product_type": "Drugs", "event_id": "84570", "recalling_firm": "Sun Pharmaceutical Industries, Inc.", "address_1": "270 Prospect Plains Rd", "address_2": "", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States to 96 distributors and 1 repacker/relabeler.", "recall_number": "D-0659-2020", "product_description": "Sumatriptan Succinate Tablets, 50 mg, packaged in a) 9 (1x9) Unit-of use blister card (NDC 62756-521-69) and b) 100 count bottles, (NDC 62756-521-88), Rx only, Sun Pharma, Cranbury, NJ", "product_quantity": "384/100 count bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.", "recall_initiation_date": "20191226", "center_classification_date": "20200113", "termination_date": "20201022", "report_date": "20200122", "code_info": "a) JKU1939A, JKU1940A, JKU1940B, exp. date 04/2022 and     b) JKT4175A, exp. date 11/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Albuquerque", "state": "NM", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86123", "recalling_firm": "Calvin Scott & Company, Inc.", "address_1": "209 Eubank Blvd Ne", "address_2": "N/A", "postal_code": "87123-2745", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1517-2020", "product_description": "Thyroid 1 Grain Tablets, 28-count bags,  Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, Manufactured by RLC Labs, Cave Creek, AZ 85331,  NDC 64727-3300-02", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.", "recall_initiation_date": "20200727", "center_classification_date": "20200820", "termination_date": "20240411", "report_date": "20200826", "code_info": "Lot #: 19233; Exp. Date: 08/20; 19254, Exp. Date 09/20; 19273, Exp. Date: 1/21"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0972-2020", "product_description": "Methylprednisolone Acetate Injectable Suspension, METHYLPREDNISOLONE ACETATE [10ML] CMC 50 MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0636-1", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 03202019+51817, Exp 4/16/2020; 09122019+52911, Exp 10/9/2020; 09132019+52918, Exp 8/12/2020"}, {"status": "Terminated", "city": "Short Hills", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207427"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Bayshore Pharmaceuticals LLC"], "product_ndc": ["76385-128", "76385-129"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["860975", "860981"], "spl_id": ["b6d19df3-bc53-4aa3-b2d3-69dbb95b7c05"], "spl_set_id": ["93c8deae-3103-4cbf-a5d1-fe0d37e76df8"], "package_ndc": ["76385-128-10", "76385-128-01", "76385-128-50", "76385-129-01", "76385-129-50"], "is_original_packager": [true], "upc": ["0376385128104"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "86280", "recalling_firm": "BAYSHORE PHARMACEUTICALS", "address_1": "788 Morris Tpke Ste 200", "address_2": "N/A", "postal_code": "07078-2634", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "nationwide", "recall_number": "D-1543-2020", "product_description": "Metformin Hydrochloride Extended-Release Tablets USP, 500 mg 1000 Tablets Rx Only Manufactured by: Beximco Pharmaceuticals, LTD. 126, Kathaldia, Tongi, Gazipur, 1711, Bangladesh  NDC 76385-128-10", "product_quantity": "594 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20200819", "center_classification_date": "20200825", "termination_date": "20210426", "report_date": "20200902", "code_info": "Lot #18641; Exp. 05/2021"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85239", "recalling_firm": "Akorn Inc", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1258-2020", "product_description": "Fentanyl Citrate Injection, USP, 100 mcg/2 mL (50 mcg/mL), 10 Ampules per carton, (2 mL each), Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-030-02", "product_quantity": "15,170 ampules", "reason_for_recall": "Failed impurities/degradation specification: Out-of-Specification result for total impurity at 4.1% (Limit: NMT 3.0%) during retained sample testing.", "recall_initiation_date": "20200325", "center_classification_date": "20200501", "termination_date": "20220728", "report_date": "20200408", "code_info": "Lot 081887A, EXP 08/2021"}, {"status": "Terminated", "city": "Polepally, Jadcherla", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA208302"], "brand_name": ["IMATINIB MESYLATE"], "generic_name": ["IMATINIB MESYLATE"], "manufacturer_name": ["Armas Pharmaceuticals Inc."], "product_ndc": ["72485-202"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IMATINIB MESYLATE"], "rxcui": ["403878"], "spl_id": ["f3d17411-8424-4c6d-b244-47f125f17f31"], "spl_set_id": ["2e931c49-6c9f-41e2-a34b-5f01cd295b56"], "package_ndc": ["72485-202-90"], "is_original_packager": [true], "unii": ["8A1O1M485B"]}, "product_type": "Drugs", "event_id": "86749", "recalling_firm": "Shilpa Medicare Limited", "address_1": "S-20 To S-26,  Pharm. Formulation Sez", "address_2": "Tsiic, Green Industrial Park", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0124-2021", "product_description": "Imatinib Mesylate Tablets 100 mg, Rx Only, 90-count Bottle, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals Inc., Manalapan, NJ 07726, NDC 72485-202-90.", "product_quantity": "2611 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20201208", "center_classification_date": "20201209", "termination_date": "20220311", "report_date": "20201216", "code_info": "Lot #s: 7S10033B, 7S10033A, 7S10031A, Exp. 02/28/2021."}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1131-2020", "product_description": "Hernia Off, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1114-2020", "product_description": "Cellulite Off, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0768-2020", "product_description": "SUFENTANIL 300MCG/ML  INJ in 20 mL syringe Assurance Infusion (713)-533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@9 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Fort Worth", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86171", "recalling_firm": "Eosera, Inc.", "address_1": "5000 South Fwy Ste 106", "address_2": "N/A", "postal_code": "76115-3902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1498-2020", "product_description": "Ear Pain MD Pain Relief Drops For Kids (lidocaine HCl Monohydrate 4%) 0.5 FL OZ (15 mL) bottles, Eosera, Inc. 5000 South Freeway Fort Worth, TX 76115, NDC 72429-0070-8", "product_quantity": "45,673 bottles", "reason_for_recall": "cGMP Deviations.", "recall_initiation_date": "20200804", "center_classification_date": "20200813", "termination_date": "20210910", "report_date": "20200819", "code_info": "Lots: P203093 Exp. DEC 21; P203026 Exp. JUN 21; P193084, P193044, Exp. APR 21; P193073, P193072, P193071,  P193070 Exp. FEB 21; P192050 Exp. MAY 21;  P193042 Exp. MAR 21; P193013 Exp. JAN 21; P193012 Exp. DEC 20"}, {"status": "Terminated", "city": "Maumee", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85978", "recalling_firm": "Spartan Chemical Co Inc", "address_1": "1110 Spartan Dr", "address_2": "", "postal_code": "43537-1725", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide USA, Panama, St. Maarten", "recall_number": "D-1503-2020", "product_description": "Lemon Blossom Hand Sanitizer (benzalkonium chloride 0.1%  - antimicrobial), For Institutional and Industrial Use Only, a) foamyiQ 42.27 oz/1250 mL cartridge, UPC code: 7 53727 26454 4; b) Lite 'n Foamy 1 gallon/3.79 L container UPC code: 7 53727 26113 0, Spartan Chemical Company, Inc., 1110 Spartan Drive, Maumee, OH 43537 USA.", "product_quantity": "a) 60,796 cartridges, b) 420 gallon containers", "reason_for_recall": "Microbial contamination of non-sterile products: positive microbial contamination in product.", "recall_initiation_date": "20200701", "center_classification_date": "20200814", "termination_date": "20231016", "report_date": "20200812", "code_info": "a) 42.27 oz cartridge: 518491, 518492, 518498, 518499, 518500, 520057, 520058, 520060, 520061; b) 1 gallon container: 520032, Exp. 06/30/2022.", "more_code_info": ""}, {"status": "Terminated", "city": "Cherry Hill", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091032"], "brand_name": ["IRINOTECAN HYDROCHLORIDE"], "generic_name": ["IRINOTECAN HYDROCHLORIDE"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0143-9583"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["IRINOTECAN HYDROCHLORIDE"], "rxcui": ["1726324"], "spl_id": ["e36c07c2-a7ad-4d59-bdcc-fe16765b264b"], "spl_set_id": ["9c6aa884-750e-4b11-9955-bc7ab6e9c2ad"], "package_ndc": ["0143-9583-01"], "is_original_packager": [true], "unii": ["042LAQ1IIS"]}, "product_type": "Drugs", "event_id": "85831", "recalling_firm": "Hikma Pharmaceuticals USA Inc.", "address_1": "2 Esterbrook Ln", "address_2": "", "postal_code": "08003-4002", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1309-2020", "product_description": "Irinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Shiffgraben 23, 38690 Golsar, Germany  Distributed by: West-Word Pharmaceutical Corp. Eatontown, NJ 07724 USA, NDC 0143-9583-01", "product_quantity": "17,998 vials", "reason_for_recall": "Defective Container: Customer complaints received of a crimp defect while removing the flip-cap during use.", "recall_initiation_date": "20200611", "center_classification_date": "20200612", "termination_date": "20210610", "report_date": "20200624", "code_info": "Lot #:AC0231A, exp. date 08/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1176-2020", "product_description": "Testosterone W/Cosmetic HRT Base 100 MG (10%) Cream 30 GM, tubes Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "4 tubes", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45027 Discard by: 07/27/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0690-2020", "product_description": "BUP 2.5MG/FENT 25MCG/HYDRO 2MG/MORP 40MG/ML in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12102019@3 Exp. 12/19/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203817"], "brand_name": ["MESALAMINE"], "generic_name": ["MESALAMINE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-2245"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MESALAMINE"], "rxcui": ["686429"], "spl_id": ["1300887a-c110-46b3-a8be-cfceabf0cbf2"], "spl_set_id": ["ba1e3bd4-fbe0-46a5-961e-167ccb09672c"], "package_ndc": ["0591-2245-22"], "is_original_packager": [true], "upc": ["0305912245229"], "nui": ["N0000175781", "M0000971"], "pharm_class_epc": ["Aminosalicylate [EPC]"], "pharm_class_cs": ["Aminosalicylic Acids [CS]"], "unii": ["4Q81I59GXC"]}, "product_type": "Drugs", "event_id": "85017", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0862-2020", "product_description": "Mesalamine Delayed-Release Tablets, USP, 1.2 gram, 120-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL  33314; Distributed by: Actavis Pharma, Inc., Parsippany, NJ  07054; NDC 0591-2245-22.", "product_quantity": "3,695 bottles", "reason_for_recall": "Failed Dissolution Specifications: Low out of specification dissolution result observed during stability testing.", "recall_initiation_date": "20200220", "center_classification_date": "20200302", "termination_date": "20201006", "report_date": "20200311", "code_info": "Lot #: 1342500A, Exp 10/2020"}, {"status": "Terminated", "city": "Tlalnepantla", "state": "N/A", "country": "Mexico", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86037", "recalling_firm": "AAA Cosmetica, SA de CV", "address_1": "Calle Recursos Hidraulicos 1", "address_2": "Pueblo La Loma, Tlalnepantla De Baz", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1569-2020", "product_description": "bio aaa Advance Hand Sanitizer Ethyl Alcohol 70%, Unscented, 16.23 Oz (480 mL), Distributed By: Payless Janitorial Corporation 1341 SW 21 Terrance, Fort Lauderdale, Florida  Exported By: E. Audicode S.A. de C.V. Manufactured By: AAA Cosmetica S.A. de C.V.  UPC  7 502272 12111 5", "product_quantity": "21,228  bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20200702", "center_classification_date": "20200911", "termination_date": "20240116", "report_date": "20200909", "code_info": "Lots:  All lots to include 20DF9005, 20DF9006, EXP April 2022"}, {"status": "Terminated", "city": "Albuquerque", "state": "NM", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86123", "recalling_firm": "Calvin Scott & Company, Inc.", "address_1": "209 Eubank Blvd Ne", "address_2": "N/A", "postal_code": "87123-2745", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1529-2020", "product_description": "Phentermine HCL Blue/White Capsules, 37.5 mg, 28-count bags,  Rx only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, MFG: KVK-Tech., Inc Newtown, PA 18940; NDC 10702-0029-10", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.", "recall_initiation_date": "20200727", "center_classification_date": "20200820", "termination_date": "20240411", "report_date": "20200826", "code_info": "Lot #:19219; Exp. Date: 08/20"}, {"status": "Terminated", "city": "South Richmond Hill", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85992", "recalling_firm": "MasterPharm LLC", "address_1": "11502 Liberty Ave Fl 2", "address_2": "N/A", "postal_code": "11419-1902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1438-2020", "product_description": "Tadalafil 26 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600", "product_quantity": "900 capsules", "reason_for_recall": "Lack of Processing Controls (lack of assurance of conformity to specifications).", "recall_initiation_date": "20200702", "center_classification_date": "20200729", "termination_date": "20240223", "report_date": "20200805", "code_info": "01-27-2020:91@23, BUD 7/25/2020  02-26-2020:57@16, BUD 8/24/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0703-2020", "product_description": "BUP 35MG/FENT 1.5MG/ML in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12112019@17 Exp. 12/20/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84127", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1013-2020", "product_description": "Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 60 tablets per bottle. [NDC: Brand] NDC Health Mart: 62011-0283-2; NDC Major: 0904-6715-52; NDC Meijer: 41250-252-72;  NDC Sunmark: 49348-136-12;", "product_quantity": "", "reason_for_recall": "CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.", "recall_initiation_date": "20191023", "center_classification_date": "20200313", "termination_date": "20201106", "report_date": "20200325", "code_info": "Lots: 8DE1367,   8EE1559,   8FE1451,   8GE1340,   8HE1222,   8KE2831,   8JE1917,   8KE2245 ,  8ME2724,   9AE2831,   9DE2747,   9CE3339,   9EE2636,   9FE2971,   9GE2793,   9GE3220", "more_code_info": ""}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1215-2020", "product_description": "Bi-Est (8:2)/Progesterone 2/100 mg/mL capsule 90 caps bottle, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 bottle", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45239 Discard by: 9/16/2020", "more_code_info": ""}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202800"], "brand_name": ["ACETAMINOPHEN AND CODEINE PHOSPHATE"], "generic_name": ["ACETAMINOPHEN AND CODEINE PHOSPHATE"], "manufacturer_name": ["Aurolife Pharma, LLC"], "product_ndc": ["13107-058", "13107-059", "13107-060"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN", "CODEINE PHOSPHATE"], "rxcui": ["993770", "993781", "993890"], "spl_id": ["4c82ae3f-5e61-4b95-821f-1e9a1775682e"], "spl_set_id": ["02386806-02d4-47e3-9c8b-7810146ee795"], "package_ndc": ["13107-058-30", "13107-058-01", "13107-058-05", "13107-058-99", "13107-059-30", "13107-059-01", "13107-059-05", "13107-059-99", "13107-060-30", "13107-060-01", "13107-060-05", "13107-060-99"], "is_original_packager": [true], "unii": ["362O9ITL9D", "GSL05Y1MN6"]}, "product_type": "Drugs", "event_id": "85183", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1230-2020", "product_description": "Acetaminophen and Codeine Phosphate Tablets, USP, 300 mg/30 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ 08810, NDC 13107-059-99", "product_quantity": "4332 units", "reason_for_recall": "CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed", "recall_initiation_date": "20200318", "center_classification_date": "20200413", "termination_date": "20240325", "report_date": "20200422", "code_info": "Lot #: 059180023A, 059180024A and 059180025A, Exp. Date 05/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1138-2020", "product_description": "Herpes-P, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86343", "recalling_firm": "RLC Labs Inc.", "address_1": "1850 E Riverview Dr", "address_2": "N/A", "postal_code": "85034-6703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-1616-2020", "product_description": "Nature Throid, 3/4 Grain (48.75 mg) Thyroid USP [Liothyronine (T3) 6.75 mcg, Levothyroxine (T4) 28.5 mcg], packaged in a) 100-count bottles (NDC 64727-3302-1) and b) 1000-count bottles (NDC 64727-3302-2), Rx only,  Manufactured by: RLC Labs Phoenix, AZ 85034", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug: FDA analysis found product to be subpotent", "recall_initiation_date": "20200825", "center_classification_date": "20200924", "termination_date": "20231108", "report_date": "20200923", "code_info": "Lot #: 109242, Exp. Date 11/2022"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0774-2020", "product_description": "TRIMIX (UA) 30MG/1MG/20MCG/ML INJ in 1 mL vial  Assurance Infusion (713) 533-8800", "product_quantity": "1 vial", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 11042019@28 Exp. 05/02/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84671", "recalling_firm": "Preferred Pharmaceuticals, Inc", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distribution to physicians in the following states: AL, AZ, CA, FL, GA, IN, and  SC", "recall_number": "D-0796-2020", "product_description": "Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 150 mg, a) 30 count bottles (NDC: 68788-7388-3), b) 60 count bottles (NDC: 68788-7388-6), c) 90 count bottles (NDC: 68788-7388-9), d) 100 count bottles (NDC: 68788-7388-1)", "product_quantity": "221,710 tablets", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20200107", "center_classification_date": "20200120", "termination_date": "20231214", "report_date": "20200129", "code_info": "Lot #: All lots within expiry", "more_code_info": ""}, {"status": "Terminated", "city": "Vancouver", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85784", "recalling_firm": "Beaming White Llc", "address_1": "1205 Ne 95th St", "address_2": "Suite A", "postal_code": "98665-8960", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1359-2020", "product_description": "Koala Hand Sanitizer, Unscented, 16 FL OZ.,  Antibacterial, (Ethyl Alcohol 70%), Manufactured by Beaming White LLC, 1205 NE 95th St., Vancouver, WA 98665", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug: active ingredient ethanol tested below label claim and there is presence of undeclared isopropyl alcohol.", "recall_initiation_date": "20200612", "center_classification_date": "20200626", "termination_date": "20240311", "report_date": "20200708", "code_info": "Lot#: 42220, Exp. Date 4/22/23"}, {"status": "Terminated", "city": "Ciudad De Mexico", "state": "N/A", "country": "Mexico", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86327", "recalling_firm": "Asiaticon, SA de CV", "address_1": "Conkal No. 62", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed in Texas", "recall_number": "D-0117-2021", "product_description": "Protz real protection Antibacterial Hand Sanitizer, Ethyl Alcohol 70%, 13.5 FL OZ (400 mL), Distributed by: Safety-Med Products, Inc. Burlington, WI 53105 Made in Mexico by Asiaticon S.A. de C.V. Conkal No. 62, Mexico, Ciudad de Mexico 14200, Mexico NDC: 75192-600-02 UPC 7 503019 005002", "product_quantity": "111,500 units", "reason_for_recall": "Lack of CGMPs:", "recall_initiation_date": "20200825", "center_classification_date": "20201207", "termination_date": "20230517", "report_date": "20201216", "code_info": "All lots."}, {"status": "Terminated", "city": "Celaya", "state": "N/A", "country": "Mexico", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86858", "recalling_firm": "Simex Logistics SA de CV", "address_1": "Calle Salvatierra Fracc. El Puente 101", "address_2": "Col. Santa Maria, Celaya", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, GA, NV, TX", "recall_number": "D-0163-2021", "product_description": "UVT World Gel Hand Sanitizer 70% Alcohol Content, 33.9 FL OZ (1LT), Distributed By UVT World Newport Beach, CA 92660 www.uvt.world Produced By: Simex Logistics S.A. de C.V. Salvatierra No. 101 Fraccionamiento El Puente Celaya, Guanajuato, Mexico Barcode: 7 00306 88677 2", "product_quantity": "16308 bottles", "reason_for_recall": "Subpotent drug", "recall_initiation_date": "20201125", "center_classification_date": "20201216", "termination_date": "20230517", "report_date": "20201223", "code_info": "Lot: 0-620, Exp 08/05/2023"}, {"status": "Terminated", "city": "South Richmond Hill", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85619", "recalling_firm": "MasterPharm LLC", "address_1": "11502 Liberty Ave Fl 2", "address_2": "N/A", "postal_code": "11419-1902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1269-2020", "product_description": "Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.", "product_quantity": "7260 capsules", "reason_for_recall": "Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.", "recall_initiation_date": "20200414", "center_classification_date": "20200519", "termination_date": "20230907", "report_date": "20200520", "code_info": "Lot #02-27-2020:04@11, Exp. August 25, 2020."}, {"status": "Terminated", "city": "East Haven", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86579", "recalling_firm": "Milbar Laboratories, Inc.", "address_1": "20 Commerce St", "address_2": "N/A", "postal_code": "06512-4145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States, including Puerto Rico and internationally.", "recall_number": "D-0089-2021", "product_description": "(Malin + Goetz) Salicylic Gel (2% Salicylic Acid) 0.5 fl.oz. 15 mL tube, Distributed by: Malin+Goetz Inc 330 Seventh Avenue, New York, New York, 10001", "product_quantity": "2,664 tubes", "reason_for_recall": "GMP Deviations", "recall_initiation_date": "20201009", "center_classification_date": "20201117", "termination_date": "20230104", "report_date": "20201125", "code_info": "Lot #: MV678, Exp. Date Dec-21"}, {"status": "Ongoing", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078596"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "product_ndc": ["65162-178", "65162-179"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["860975", "860981"], "spl_id": ["984302ad-793e-4f35-92da-e5e7f92154f6"], "spl_set_id": ["c01a79e0-f2b7-4d99-857e-bda7f24fe319"], "package_ndc": ["65162-178-89", "65162-178-03", "65162-178-09", "65162-178-10", "65162-178-50", "65162-178-11", "65162-179-03", "65162-179-09", "65162-179-10", "65162-179-50"], "is_original_packager": [true], "upc": ["0365162178104", "0365162179101"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "85781", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "N/A", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1345-2020", "product_description": "amneal Metformin Hydrochloride Extended-release Tablets, USP, 500 mg Rx Only, 500 Tablets bottles, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Ahmedabad 388213, INDIA Distributed by: Amneal Pharmaceuticals LLC Bridgewater, NJ 08807   NDC 65162-178-50", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level", "recall_initiation_date": "20200529", "center_classification_date": "20200625", "report_date": "20200701", "code_info": "AM180641A 6/30/2020  AM180642A 6/30/2020  AM180643A 6/30/2020  AM180644A 6/30/2020  AM180645A 6/30/2020  AM180646A 6/30/2020  AM180647A 6/30/2020  AM180880A 7/31/2020  AM180881A 7/31/2020  AM180882A 7/31/2020  AM180883A 7/31/2020  AM180884A 7/31/2020  AM180885A 7/31/2020  AM180886A 7/31/2020  AM180887A 7/31/2020  AM180888A 7/31/2020  AM180889A 7/31/2020  AM180936A 7/31/2020  AM180937A 7/31/2020  AM180938A 7/31/2020  AM180939A 7/31/2020  AM180940A 7/31/2020  AM180960A 7/31/2020  AM180961A 7/31/2020  AM180962A 7/31/2020  AM180963A 7/31/2020  AM180964A 7/31/2020  AM180965A 7/31/2020  AM180992A 7/31/2020  AM180993A 7/31/2020  AM180994A 8/31/2020  AM180995A 8/31/2020  AM180996A 8/31/2020  AM180997A 8/31/2020  AM181037A 8/31/2020  AM181038A 8/31/2020  AM181039A 8/31/2020  AM181040A 8/31/2020  AM181041A 8/31/2020  AM181079A 8/31/2020  AM181080A 8/31/2020  AM181081A 8/31/2020  AM181082A 8/31/2020  AM181083A 8/31/2020  AM181084A 8/31/2020  AM181085A 8/31/2020  AM181086A 8/31/2020  AM181087A 8/31/2020  AM181088A 8/31/2020  AM181089A 8/31/2020  AM181093A 8/31/2020  AM181094A 8/31/2020  AM181095A 8/31/2020  AM181096A 8/31/2020  AM181097A 8/31/2020  AM181098A 8/31/2020  AM181099A 8/31/2020  AM181100A 8/31/2020  AM181101A 8/31/2020  AM181102A 8/31/2020  AM181116A 8/31/2020  AM181117A 9/30/2020  AM181129A 8/31/2020  AM181130A 8/31/2020  AM181131A 8/31/2020  AM181132A 8/31/2020  AM181133A 9/30/2020  AM181134A 9/30/2020  AM181135A 9/30/2020  AM181136A 9/30/2020  AM181137A 9/30/2020  AM181138A 9/30/2020  AM181183A 9/30/2020  AM181184A 9/30/2020  AM181185A 9/30/2020  AM181186A 9/30/2020  AM181187A 9/30/2020  AM181188A 9/30/2020  AM181189A 9/30/2020  AM181190A 9/30/2020  AM181235A 9/30/2020  AM181236A 9/30/2020  AM181237A 9/30/2020  AM181238A 9/30/2020  AM181239A 9/30/2020  AM181240A 9/30/2020  AM181242A 9/30/2020  AM181243A 9/30/2020  AM181314A 10/31/2020  AM181315A 11/30/2020  AM190121B 12/31/2020  AM190122B 12/31/2020  AM190713AA 6/30/2021  AM191248A 10/31/2021  AM191249A 10/31/2021  AM200192 1/31/2022  AM200322A 2/28/2022"}, {"status": "Terminated", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M001"], "brand_name": ["GAVISCON"], "generic_name": ["ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE"], "manufacturer_name": ["Haleon US Holdings LLC"], "product_ndc": ["0135-0094", "0135-0095", "0135-0574"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ALUMINUM HYDROXIDE", "MAGNESIUM CARBONATE"], "rxcui": ["245001", "252203", "404472", "1251365"], "spl_id": ["4cfa1b72-26c3-495b-9d5a-2026d6b82def"], "spl_set_id": ["2d74e5bc-1f10-4fb6-9258-cd906e360013"], "package_ndc": ["0135-0094-41", "0135-0094-42", "0135-0095-41", "0135-0574-01"], "is_original_packager": [true], "unii": ["0E53J927NA", "5QB0T2IUN0"]}, "product_type": "Drugs", "event_id": "85755", "recalling_firm": "Glaxosmithkline Consumer Healthcare Holdings", "address_1": "184 Liberty Corner Rd", "address_2": "", "postal_code": "07059-6796", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1322-2020", "product_description": "Gaviscon Regular Strength Liquid Antacid Cool Mint, 6 FL OZ (177 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0094-42", "product_quantity": "119,364 bottles", "reason_for_recall": "Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.", "recall_initiation_date": "20200528", "center_classification_date": "20200618", "termination_date": "20220124", "report_date": "20200624", "code_info": "Lot #: 8M17C1, Exp 11/30/2020; 9E30C1, Exp 4/30/2021; 9F05C1, Exp 4/30/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Oklahoma City", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86533", "recalling_firm": "PD-Rx Pharmaceuticals, Inc.", "address_1": "727 N Ann Arbor Ave", "address_2": "N/A", "postal_code": "73127-5822", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "AZ, OK", "recall_number": "D-0005-2021", "product_description": "Nature-Throid 1 GR (65 mg), Each Tablet Contains: Thyroid USP 1 GR (65 mg), Liothyronine (T3) 9 mcg, Levothyroxine (T4) 38 mcg, 100 Tablets per bottle, Rx Only, Pkg By PD-Rx Pharmaceuticals Incorporated, Oklahoma City, OK 73127, NDC 43063-819-01.", "product_quantity": "20 bottles", "reason_for_recall": "CGMP deviations; repackaged product was recalled by the manufacturer because it was manufactured under the same conditions as products found to be sub-potent.", "recall_initiation_date": "20200917", "center_classification_date": "20201002", "termination_date": "20211105", "report_date": "20201014", "code_info": "Lot #: J18C68 Exp. 10/31/20"}, {"status": "Terminated", "city": "Tlalnepantla De Baz", "state": "N/A", "country": "Mexico", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86105", "recalling_firm": "Real Clean Distribuciones SA de CV", "address_1": "Recursos Petroleros", "address_2": "Fracc Industrial La Loma 3; Tlalnepantla De Baz", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1579-2020", "product_description": "scent theory KEEP IT CLEAN, pure clean,(Ethyl Alcohol 70%), 16.9 FL OZ/500 mL, Distributed by Scent Theory Products, LLC New York, NY 10018, Made in Mexico, UPC 8 40038 21434 1", "product_quantity": "504,000 pieces", "reason_for_recall": "CGMP Deviations: Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.", "recall_initiation_date": "20200723", "center_classification_date": "20200911", "termination_date": "20220527", "report_date": "20200923", "code_info": "Lots: 0133220, 0233220, 0333220, 0433220, 0533220, 0633220, 0733220, 0833220, 0933220, 1033220 1133220, 1233220, 1333220, 1433220, 1533220"}, {"status": "Terminated", "city": "South Richmond Hill", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85992", "recalling_firm": "MasterPharm LLC", "address_1": "11502 Liberty Ave Fl 2", "address_2": "N/A", "postal_code": "11419-1902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1442-2020", "product_description": "Vardenafil 20 mg Troche, 30 troches per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600", "product_quantity": "134 troches", "reason_for_recall": "Lack of Processing Controls (lack of assurance of conformity to specifications).", "recall_initiation_date": "20200702", "center_classification_date": "20200729", "termination_date": "20240223", "report_date": "20200805", "code_info": "01-21-2020:42@8, BUD 7/19/2020  01-24-2020:59@1, BUD 7/22/2020  02-04-2020:65@11, BUD 8/2/2020"}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1186-2020", "product_description": "Bi-Est (1:1) Progest/Test 0.5 mg/40 mg/10.5 mg/mL Cream 30 gm tube, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 tube", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 44894 Discard by: 6/15/2020", "more_code_info": ""}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "84620", "recalling_firm": "Idelle Labs", "address_1": "One Helen Of Troy Plaza", "address_2": "N/A", "postal_code": "79912", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0786-2020", "product_description": "SURE 48hr Confidence Unscented Original Solid Anti-Perspirant & Deodorant Net Wt 2.7 oz (76g) NDC# 41595-5513-2 UPC 8 83484 71794 3  Made in Canada and Distributed by Idelle Labs, Ltd., El Paso, TX 79912", "product_quantity": "Unknown", "reason_for_recall": "Labeling Product Contains Undeclared API: Active Ingredient on label is not the active ingredient in the product.", "recall_initiation_date": "20191120", "center_classification_date": "20200116", "termination_date": "20220928", "report_date": "20200115", "code_info": "Lots: 19277K2, 19278K1"}, {"status": "Terminated", "city": "Albuquerque", "state": "NM", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86123", "recalling_firm": "Calvin Scott & Company, Inc.", "address_1": "209 Eubank Blvd Ne", "address_2": "N/A", "postal_code": "87123-2745", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1530-2020", "product_description": "Phentermine HCL White/Blue Speck Tabs 37.5 mg, 28-count bags, Rx only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123 Manufactured by SUN Pharmaceuticals, NDC 53489-0676-10", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.", "recall_initiation_date": "20200727", "center_classification_date": "20200820", "termination_date": "20240411", "report_date": "20200826", "code_info": "Lot #:19207; Exp. Date: 9/21; 19251, Exp. Date: 9/20; 19284, Exp. Date:10/20; 19316, Exp. Date: 12/20"}, {"status": "Terminated", "city": "Dayton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85212", "recalling_firm": "PharMEDium Services, LLC", "address_1": "36 Stults Rd", "address_2": "N/A", "postal_code": "08810", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-1087-2020", "product_description": "rocuronium Bromide, 10 mg per mL, 50 mg per 5 mL, 5 mL BD Syringe, for IV Use, PharMEDium 13N. Davis Ave. Cleveland MS 36732. NDC 71019-321-05", "product_quantity": "2250 units", "reason_for_recall": "Firm is recalling 46 lots of various products because of a lack of sterility assurance.", "recall_initiation_date": "20200316", "center_classification_date": "20200406", "termination_date": "20250214", "report_date": "20200415", "code_info": "193500019D  3/16/2020  193510014D  3/17/2020  193520009D  3/18/2020"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86022", "recalling_firm": "4e Brands North America, Llc", "address_1": "17806 Ih-10 Ste 300", "address_2": "N/A", "postal_code": "78257", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0022-2021", "product_description": "blumen ADVANCED INSTANT HAND SANITIZER Clear ETHYL ALCOHOL 70% Natural Boost with Tea Tree Oil, (70% ethyl alcohol), Packaged as a) 18 fl oz / 532 ml bottle, UPC 8 14266 02408 9 b) 33.8 fl oz / 1L bottle, UPC  8 14266 02374 7, Distributed in USA and Canada BY: 4e Brands Northamerica LLC. 17806 IH-10W, Suite 300, San Antonio, Texas, 78257. Made in Mexico.", "product_quantity": "17,359,247 total bottles and pumps", "reason_for_recall": "CGMP Deviations: recalled because it was manufactured in the same facility as the product found to contain methanol which represents poor Current Good Manufacturing Practices.", "recall_initiation_date": "20200711", "center_classification_date": "20201007", "termination_date": "20240226", "report_date": "20201007", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0771-2020", "product_description": "TESTOSTERONE CYP 200MG/ML OIL  (SESAME)  INJ in 10 mL vial Assurance Infusion (713) 533-8800", "product_quantity": "7 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 08212019@17 Exp. 02/17/2020; 10232019@23 Exp. 04/20/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0944-2020", "product_description": "BETAMETHASONE ACETATE/BETAMETHASONE (PF) Injectable Suspension, Betamethasone Acetate/Betamethasone (PF) CMC [5ML] 7MG/ML INJ SUSP, For IM, IA Use, Shake Well. 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0621-5", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 07232019+52738, Exp 2/20/2020"}, {"status": "Terminated", "city": "Albuquerque", "state": "NM", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86123", "recalling_firm": "Calvin Scott & Company, Inc.", "address_1": "209 Eubank Blvd Ne", "address_2": "N/A", "postal_code": "87123-2745", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1531-2020", "product_description": "Phentermine HCL White/Blue Speckled tablets, 37.5 mg, packaged in a) 7-count bags, and b) 28-count bags, Rx only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, Manufactured by Lannett Company, Inc. Philadelphia, PA 19136;  NDC 00527-1445-10", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.", "recall_initiation_date": "20200727", "center_classification_date": "20200820", "termination_date": "20240411", "report_date": "20200826", "code_info": "Lot # a) and b) 19350; Exp. Date: 1/21"}, {"status": "Terminated", "city": "Piscataway", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84610", "recalling_firm": "Appco Pharma LLC", "address_1": "262 Old New Brunswick Rd Unit N", "address_2": "N/A", "postal_code": "08854-3756", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed to 6 major distributors/wholesalers some with multiple locations who may have further distribute the product.", "recall_number": "D-0649-2020", "product_description": "Ranitidine Capsules 150 mg, (a) 60 count bottles (NDC 62559-690-60) , (b) 500 count bottles (NDC 62559-690-05), Rx only, Manufactured by: Appco Pharma LLC, Piscataway, NJ 08854, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623.", "product_quantity": "624 bottes", "reason_for_recall": "CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API", "recall_initiation_date": "20200107", "center_classification_date": "20200107", "termination_date": "20200424", "report_date": "20200115", "code_info": "Batch #   1905225VN, exp. date Apr-2021  1905226VD, exp. date Apr-2021  1906295UN, exp. date May-2021  1906296UN, exp. date May-2021  1906297UN, exp. date May-2021  1906298UD, exp. date May-2021"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1126-2020", "product_description": "Fungo Balm, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-  0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84527", "recalling_firm": "MPRX, Inc. dba Medical Park Pharmacy", "address_1": "8230 Elmbrook Dr Ste 600b", "address_2": "N/A", "postal_code": "75247-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0817-2020", "product_description": "T3/T4 SR 9 mcg/38 mcg capsule", "product_quantity": "2 bottles", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.", "recall_initiation_date": "20191218", "center_classification_date": "20200129", "termination_date": "20221213", "report_date": "20200205", "code_info": "Lot: 61296:42Use by: 04/13/2020"}, {"status": "Ongoing", "city": "Villa Nueva", "state": "N/A", "country": "Guatemala", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86427", "recalling_firm": "Genesis Partnership Company SA", "address_1": "Km 19.5 Carretera Al Pacifico, Bodega 28", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0041-2021", "product_description": "Killz Germz Hand Sanitizer, Alcohol Gel, 1 Gallon (128 fl. oz.) bottle, Manufactured by Genesis Partnership Company S.A., Guatemala, For: Killz Germz, LLC., 1912 R street NW, Washington DC 20009, NDC 74625-003-05, UPC 7401037203427.", "product_quantity": "8600 bottles", "reason_for_recall": "Sub-Potent Drug; Killz GERMz was recalled due to sub-potent results. Testing revealed ethanol levels as low as 62% while labelled claim is 70%.", "recall_initiation_date": "20200911", "center_classification_date": "20201019", "report_date": "20201028", "code_info": "Lot #s: 36748, 36818, 36697, Exp. 10/15/21 and 11/8/21"}, {"status": "Terminated", "city": "East Haven", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86579", "recalling_firm": "Milbar Laboratories, Inc.", "address_1": "20 Commerce St", "address_2": "N/A", "postal_code": "06512-4145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States, including Puerto Rico and internationally.", "recall_number": "D-0090-2021", "product_description": "(Malin+Goetz) spf 30 face moisturizer (Avobenzone 3%, Homosalate 10 %, Octinoxate 7.5%, Octisalate 2.75%, Oxybenzone 5%) 1.7 fl. oz. 50 ml tubes, Distributed by: Malin+Goetz Inc 330 Seventh Avenue, New York, New York, 10001", "product_quantity": "3,692 tubes", "reason_for_recall": "GMP Deviations", "recall_initiation_date": "20201009", "center_classification_date": "20201117", "termination_date": "20230104", "report_date": "20201125", "code_info": "Lot #: AW761-9, Exp. Date Jan-22"}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1180-2020", "product_description": "Naltrexone (Loxoral) 4.5 mg Capsules, 60 count bottle, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 bottle", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 44898 Discard by: 3/23/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0989-2020", "product_description": "Triamcinolone Diacetate Injectable Suspension, TRIAMCINOLONE Diacetate [10ML] CMC 10MG/ML INJ SUSP, For IM, IA Use, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0625-1", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 10102019+53104, Exp 5/4/2020"}, {"status": "Terminated", "city": "Ontario", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86546", "recalling_firm": "ASHTEL STUDIOS, INC.", "address_1": "1610 E Philadelphia St", "address_2": "N/A", "postal_code": "91761-5759", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Pouches of .84 oz.hand sanitizer were distributed to the following states: CA, IL, and Ontario Canada", "recall_number": "D-0098-2021", "product_description": "Smart Care HAND SANITIZER, Ethyl Alcohol 62%, packaged in 0.84 FL.OZ (25 mL), labeled as   a) Paw Patrol (Item #: 92321-144, UPC 8 50016 92321 9, NDC 70108-042-01); b) JoJo Siwa Dreamer (Item #: 92320-144, UPC 8 50016 92320 2, NDC 70108-044-01);  c) Hot Wheels (Item #: 92317-144, UPC 8 50016 92317 2, NDC 70108-045-01); d) Barbie (Item #: 92318-144, UPC 8 50016 92318 9, NDC 70108-046-01);  e) Trolls (Item #: 92322-144, UPC 8 50016 92322 6, NDC 70108-047-01); and f) Minions (Item #: 92319-144, UPC 8 50016 92319 6, NDC 70108-043-01); Distributed by Ashtel Studios Inc., Ontario, CA 91761", "product_quantity": "N/A", "reason_for_recall": "Labeling: Not Elsewhere Classified. Container packaging is made, formed or filled to be misleading, resembling food and drink pouches", "recall_initiation_date": "20201001", "center_classification_date": "20201117", "termination_date": "20240215", "report_date": "20201021", "code_info": "All lots codes within expiry"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "86802", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to three hospitals in MO & LA.", "recall_number": "D-0147-2021", "product_description": "Fentanyl, 250 mcg/ 5mL, Injection for IV or IM use, Rx only, SCA Pharmaceuticals, 8821 Knoedl Ct., Little Rock, AR 72205", "product_quantity": "4,843 syringes", "reason_for_recall": "Subpotency: Out-of-specification stability test result for low potency was obtained.", "recall_initiation_date": "20201120", "center_classification_date": "20201214", "termination_date": "20210624", "report_date": "20201223", "code_info": "Lot #: 1220021578, Exp 12/2/2020; 1220021732, Exp 12/9/2020; 1220022385, Exp 12/29/2020; 1220022582, Exp 1/6/2021"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0683-2020", "product_description": "BUP 15MG/CLON 300MCG/ FENT 1500MCG/ML(40)  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "2 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@6 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Johnson City", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207733"], "brand_name": ["NYSTATIN CREAM"], "generic_name": ["NYSTATIN CREAM"], "manufacturer_name": ["Crown Laboratories"], "product_ndc": ["0316-0221"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["NYSTATIN"], "rxcui": ["543546"], "spl_id": ["42ee71fd-bcfd-a17d-e063-6294a90ab4bb"], "spl_set_id": ["5a2b6fee-1437-0c3a-e053-2991aa0a3443"], "package_ndc": ["0316-0221-15", "0316-0221-30"], "is_original_packager": [true], "upc": ["0303160221156"], "nui": ["N0000175498", "M0017172"], "pharm_class_epc": ["Polyene Antifungal [EPC]"], "pharm_class_cs": ["Polyenes [CS]"], "unii": ["BDF1O1C72E"]}, "product_type": "Drugs", "event_id": "85833", "recalling_firm": "Crown Laboratories", "address_1": "349 Lafe Cox Dr", "address_2": "N/A", "postal_code": "37604-7469", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA.", "recall_number": "D-1339-2020", "product_description": "Nystatin Cream, USP 100,000 units per gram, 15 grams, Rx Only, Manufactured and Distributed by: Crown Laboratories, Inc. Johnson City, TN 37604, NDC 0316-0221-15", "product_quantity": "35,931 tubes", "reason_for_recall": "Subpotent Drug: Out of specification for assay at the 9-month interval for Nystatin Cream, USP.", "recall_initiation_date": "20200610", "center_classification_date": "20200624", "termination_date": "20211105", "report_date": "20200701", "code_info": "Lot: Y0378, EXP 07/2021"}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86006", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to MN.", "recall_number": "D-1387-2020", "product_description": "Carbamazepine 200 mg Tablets, 100-unit dose tablets per box, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2489-00 for box; 70518-2489-01 per unit dose.", "product_quantity": "498 tablets", "reason_for_recall": "FAILED DISSOLUTION SPECIFICATION: Low out-of-specification (OOS) dissolution results obtained during routine stability testing.", "recall_initiation_date": "20200629", "center_classification_date": "20200714", "termination_date": "20200914", "report_date": "20200722", "code_info": "Lot #: B0796217-020920, Exp. Date: 02/28/2021"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0967-2020", "product_description": "Methylcobalamin Injection, METHYLCOBALAMIN 1 MG/ML INJECTABLE, For IV, IM, SC Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0331-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 07232019+52730, Exp 1/19/2020; 07232019+52732, Exp 1/19/2020; 07242019+52748, Exp 1/20/2020; 11212019+53272, Exp 5/19/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0744-2020", "product_description": "HYDROMORPHONE 3MG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "2 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12162019@14 Exp. 12/25/2019; 12102019@19 Exp. 12/19/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86193", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S.", "recall_number": "D-1551-2020", "product_description": "Heparin Sodium 5,000 units in 0.9% Sodium Chloride 500 mL, Single Dose Container, Rx Only Injection for Intravenous Use (10 units/mL), SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC#: 70004-0650-44, Bar Code 70004065044.", "product_quantity": "366 Containers", "reason_for_recall": "Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.", "recall_initiation_date": "20200729", "center_classification_date": "20200827", "termination_date": "20210521", "report_date": "20200902", "code_info": "Lot #: 1220019289, Exp 08/21/2020."}, {"status": "Terminated", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090295"], "brand_name": ["METFORMIN HYDROCHLORIDE EXTENDED RELEASE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["direct rx"], "product_ndc": ["72189-064", "72189-150"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["860975"], "spl_id": ["2c4ea7fa-b789-8bdf-e063-6394a90a3e5a"], "spl_set_id": ["a84cf1a3-3820-cd1b-e053-2995a90acf45"], "package_ndc": ["72189-150-90", "72189-150-30", "72189-064-90", "72189-064-30"], "original_packager_product_ndc": ["51224-007", "49483-623"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "86601", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "N/A", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL", "recall_number": "D-0058-2021", "product_description": "Metformin HCL E/R 500 mg, 90 Tabs, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534  NDC 72189-064-90", "product_quantity": "88 bottles", "reason_for_recall": "CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)", "recall_initiation_date": "20201012", "center_classification_date": "20201102", "termination_date": "20210922", "report_date": "20201111", "code_info": "Lot: 04DE1902, 11DE1908 Exp. 06/30/2021"}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076477"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Sun Pharmaceutical Industries Inc."], "product_ndc": ["63304-827", "63304-828", "63304-829", "63304-830"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["24508d3d-eec0-4c5c-bfaa-d6e01a03fe80"], "spl_set_id": ["595ab888-6b55-4642-a32f-e8521821ed81"], "package_ndc": ["63304-827-90", "63304-827-05", "63304-828-90", "63304-828-05", "63304-829-90", "63304-829-05", "63304-830-90", "63304-830-05"], "is_original_packager": [true], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "85184", "recalling_firm": "Sun Pharmaceutical Industries, Inc.", "address_1": "270 Prospect Plains Rd", "address_2": "", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1047-2020", "product_description": "Atorvastatin Calcium Tablets, USP 40 mg, Rx only, 500-count bottle, Manufactured by: Sun Pharmaceutical Industries Limited Mohali, INDIA, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 63304-829-05", "product_quantity": "1416 bottles", "reason_for_recall": "Presence of foreign substance: Foreign matter has been identified as latex glove in one lot of Atorvastatin Calcium Tablets USP 40 mg.", "recall_initiation_date": "20200309", "center_classification_date": "20200319", "termination_date": "20210209", "report_date": "20200325", "code_info": "Lot#: AA33617, Exp 03/2021", "more_code_info": ""}, {"status": "Terminated", "city": "South Richmond Hill", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85992", "recalling_firm": "MasterPharm LLC", "address_1": "11502 Liberty Ave Fl 2", "address_2": "N/A", "postal_code": "11419-1902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1421-2020", "product_description": "Estriol 8 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600", "product_quantity": "300 capsules", "reason_for_recall": "Lack of Processing Controls (lack of assurance of conformity to specifications).", "recall_initiation_date": "20200702", "center_classification_date": "20200729", "termination_date": "20240223", "report_date": "20200805", "code_info": "01-28-2020:71@3, BUD 7/26/2020"}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "86264", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was shipped to two distributors in IL and TX who may have further repackaged and distributed the product.", "recall_number": "D-1513-2020", "product_description": "Extra Strength Headache Relief (Acetaminophen 250 mg/aspirin 250 mg/Caffeine 65 mg) tablets, 2-tablet packets, Manufactured for: Convenience Valet Glendale Heights, IL 60139,", "product_quantity": "701,735 packets", "reason_for_recall": "Failed Stability Specifications: Out-of-Specification (OOS) results for the Aspirin related compound Salicylic Acid was observed.", "recall_initiation_date": "20200803", "center_classification_date": "20200820", "termination_date": "20210316", "report_date": "20200826", "code_info": "Lot #: K-8909, AK8909, Exp. Date 12/2020; AK9507, Exp. Date 03/2021;   AK9072, Exp. Date 04/2021; AK9102, AK9601, AK9679, Exp. Date 05/2021;  AK9145, K9145, Exp. Date 06/2021; AK9743, AK9830, Exp. Date 07/2021;  AK9276, Exp. Date 09/2021; AK9391, A9392, Exp. Date 12/2021; AK9505, Exp. Date 02/2022; AK9508, AK9509 Exp. Date 04/2022"}, {"status": "Ongoing", "city": "Villa Nueva", "state": "N/A", "country": "Guatemala", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86427", "recalling_firm": "Genesis Partnership Company SA", "address_1": "Km 19.5 Carretera Al Pacifico, Bodega 28", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0040-2021", "product_description": "Killz Germz Hand Sanitizer, Alcohol Gel, 450 mL (15 fl oz.) bottle, Manufactured by Genesis Partnership Company S.A., Guatemala, For: Killz Germz, LLC., 1912 R street NW, Washington DC, 20009, NDC 74625-003-04, UPC 7401037203250.", "product_quantity": "5,320 bottles", "reason_for_recall": "Sub-Potent Drug; Killz GERMz was recalled due to sub-potent results. Testing revealed ethanol levels as low as 62% while labelled claim is 70%.", "recall_initiation_date": "20200911", "center_classification_date": "20201019", "report_date": "20201028", "code_info": "Lot #s: 36748, 36818, 36697, Exp. 10/15/21 and 11/8/21"}, {"status": "Terminated", "city": "Torrance", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84550", "recalling_firm": "Asclemed USA Inc. dba Enovachem Pharmaceuticals", "address_1": "379 Van Ness Ave Ste 1403", "address_2": "N/A", "postal_code": "90501-7211", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Product was distributed to 6 physician's offices within the state of California.", "recall_number": "D-0651-2020", "product_description": "Estriol, USP, (Micronized), 0.12 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-37", "product_quantity": "42.12 gm", "reason_for_recall": "Failed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results.", "recall_initiation_date": "20191209", "center_classification_date": "20200108", "termination_date": "20230809", "report_date": "20200115", "code_info": "Lot Code/Exp. Date: 11061901, 11061803, 11281804, 11291804, 04171902,  05201901,  08121902, EXP 12/31/2020; 08161901, 10111903, EXP 5/31/2021; 11211904, 10161901, EXP 8/31/2021"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0772-2020", "product_description": "TESTOSTERONE CYP 200MG/ML OIL  INJ in 10 mL vial  Assurance Infusion (713) 533-8800", "product_quantity": "166 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 09122019@9 Exp. 03/10/2020; 09242019@9 Exp. 03/22/2020; 09192019@20 Exp. 03/17/2020; 10032019@8 Exp. 03/31/2020; 10032019@11 Exp. 03/31/2020; 10182019@5 Exp. 04/15/2020; 10242019@7 Exp. 04/21/2020; 10232019@24 Exp. 04/20/2020; 11042019@12 Exp. 05/02/2020; 11212019@3 Exp. 05/19/2020; 11212019@2 Exp. 05/19/2020; 11042019@15 Exp. 05/02/2020", "more_code_info": ""}]